
Channel 13 reported that Israel issued a NOTAM indicating Ben-Gurion Airport flights may remain restricted until at least April 16 amid ongoing attacks from Iran and Hezbollah.
Israel issued a Notice to Airmen (NOTAM) that flights at Ben-Gurion Airport are likely to be restricted until at least April 16, Channel 13 reported on Wednesday.
The decision to extend the restriction is based on an analysis of the current security situation, with Israel coming under missile and rocket fire from Iran and Hezbollah, including several sirens in central Israel near where Ben-Gurion Airport is located.
If the security situation changes, the restrictions at Ben-Gurion Airport may also be lifted before this date.
However, it cannot be ruled out that the security situation will remain unchanged, and the restrictions may be extended beyond April 16.
What is a NOTAM, and what does this message mean?
A NOTAM is an urgent notice issued to air personnel, including airlines, pilots, and traffic control, that parties may need to be aware of before the news media can spread the word.
This NOTAM means that it is likely that all foreign airlines that have not already cancelled their flights before April 16 are likely to do so, according to Channel 13's report.
LATEST POSTS
- 1
Space station changes command, setting stage for Crew 11 departure - 2
OECD: Iran war dampening global growth - 3
French and Malaysian authorities are investigating Grok for generating sexualized deepfakes - 4
Vote in favor of your #1 sort of juice - 5
Bolsonaro says hallucinatory effects of meds made him tamper with ankle tag
Parents who delay baby's first vaccines also likely to skip measles shots
Exploring the Gig Economy: Illustrations from Consultants
Climate leaders are talking about 'overshoot' into warming danger zone. Here's what it means
Hamas hands over another body in the Gaza Strip
How Much Has the Iran War Cost the Average American Per Day?
This Week In Space podcast: Episode 203 — China Rising
Roche breast cancer pill cuts risk of disease recurrence by 30% in trial
Pick Your #1 Sort Of Espresso
AbbVie plans to build out its presence in obesity market












